Patent Yard Sign in
European application, no grantEurope

Glioblastoma-derived angiogenesis inhibiting factor

EP 0752875 A1 · Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed March 3, 1995 and never granted as a European patent. Had it been granted, its 20-year term would have ended March 3, 2015.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 3, 2020.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 3, 1995
PublishedJanuary 15, 1997
GrantedNever granted
Term endedMarch 3, 2015
Application numberEP 95912696
Classification (CPC)A61P9/00 +2 more

Timeline

Timeline From EPO dates

1996199820002002200420062008201020122014Application filedMarch 3, 1995PublishedJan 15, 1997Term endedMarch 3, 2015

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.